期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Preparation and characterization of intestine PepT1-targeted calcium carbonate nanoparticles 被引量:4
1
作者 Yunqiang Deng Yao Jin +8 位作者 Chuyu He Yang Zou Yuanhang Zhou Shidi Han Chuhang Zhou Qi Liu Xinru Li Yanxia Zhou Yan Liu 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2018年第6期397-407,共11页
To improve the oral absorption of poorly water-soluble drugs by overcoming the intestinal epithelium barrier, calcium carbonate nanoparticles targeting to intestine peptide transporter 1(Pep T1) were fabricated by m... To improve the oral absorption of poorly water-soluble drugs by overcoming the intestinal epithelium barrier, calcium carbonate nanoparticles targeting to intestine peptide transporter 1(Pep T1) were fabricated by modification of the surface of calcium carbonate nanoparticles with Gly-Sar. Gly-Sar-conjugated TPGS was successfully synthesized and characterized, and coumarin 6-loaded Gly-Sar modified calcium carbonate nanoparticles were then prepared and characterized to have a nano-scaled size of about 193 nm in diameter, cracked surface morphology under a scanning electron microscope, and high drug loading efficiency(60.5±5.9)%. Moreover, the Gly-Sar-modified calcium carbonate nanoparticles exhibited better drug loading stability during the process of their transcellular transport, and evidently enhanced intestinal absorption of poorly water-soluble agents. Therefore, the designed intestine Pep T1-targeted calcium carbonate nanoparticles might have a promising potential for oral delivery of poorly water-soluble drugs. 展开更多
关键词 Calcium carbonate nanoparticles Oligopeptide transporter Gly-Sar In vitro release Intestinal absorption
原文传递
Preparation and characterization of pH-sensitive calcium carbonate-chlorin e6 nanoparticles for photodynamic therapy 被引量:2
2
作者 Jingru Wang Shuang Zhang +3 位作者 Zhuoyue Li Meiqi Xu Guangxue Wang Xuan Zhang 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2021年第11期904-911,共8页
In the present study,we combined CaCO_(3)NPs and Ce6 to construct CaCO_(3)-Ce6 nanoparticles (NPs).CaCO_(3)-Ce6 NPs were characterized in terms of particle size,zeta potential,UV-Vis absorption spectrum,fluorescence s... In the present study,we combined CaCO_(3)NPs and Ce6 to construct CaCO_(3)-Ce6 nanoparticles (NPs).CaCO_(3)-Ce6 NPs were characterized in terms of particle size,zeta potential,UV-Vis absorption spectrum,fluorescence spectrum,FTIR spectrum,and pH-responsive behavior.The reactive oxygen species (ROS) generation in vitro was measured in 4T1 cells.The results showed that CaCO_(3)-Ce6 NPs were uniform-sized NPs with excellent fluorescence properties and pH-responsive behavior.The ability of ROS generation by CaCO_(3)-Ce6 NPs was stronger compared with Ce6 in 4T1 cells because Ca;could enhance the ROS generation,which could contribute to a stronger anti-tumor effect. 展开更多
关键词 Calcium carbonate nanoparticles Chlorin e6 Photodynamic therapy Reactive oxygen species PH-RESPONSIVE
原文传递
碳酸钙复合纳米载体的制备及体外评价
3
作者 雷宇 赵健辉 +2 位作者 王艺娇 谷峙樾 刘占军 《中国医药工业杂志》 CAS CSCD 北大核心 2020年第7期874-876,877-881,共8页
采用复合模板法制备了由壳聚糖-聚甲基丙烯酸共聚物、碳酸钙组成的pH响应型核壳结构复合碳酸钙空腔纳米载体,并以盐酸多柔比星为模型药,评价了该载体的体外释放和抗肿瘤活性。结果显示,该空白纳米载体呈类球形,平均粒径为(345.8±10... 采用复合模板法制备了由壳聚糖-聚甲基丙烯酸共聚物、碳酸钙组成的pH响应型核壳结构复合碳酸钙空腔纳米载体,并以盐酸多柔比星为模型药,评价了该载体的体外释放和抗肿瘤活性。结果显示,该空白纳米载体呈类球形,平均粒径为(345.8±10.4)nm,多分散系数为0.214±0.035,ζ电位为(-48.5±2.1)mV。调节至pH 8.0可使该空白纳米载体吸附药物,最终得到载药量和包封率为(17.4±0.3)%和(78.5±3.2)%的载药纳米载体。体外释放试验中载药纳米载体表现出优越的pH响应性,即在pH 7.4介质中24 h累积释放率低于10%,在pH 6.8和pH 5.5介质中则可达到40%和70%。HepG2细胞毒性试验表明,共聚物、空白纳米载体均无明显细胞毒性,而载药纳米载体对HepG2细胞有显著的浓度依赖性抑制作用。结果表明这种壳核结构纳米载体有作为治疗肝癌的pH敏感载体的应用前景。 展开更多
关键词 盐酸多柔比星 碳酸钙米粒 壳核结构 复合米载体 体外释放 抗肿瘤活性
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部